Wilmington Savings Fund Society’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$759K Buy
1,963
+117
+6% +$43.4K 0.02% 352
2026
Q1
$540K Buy
1,846
+225
+14% +$73.9K 0.01% 402
2025
Q4
$568K Sell
1,621
-150
-8% -$50.7K 0.01% 398
2025
Q3
$572K Sell
1,771
-1,768
-50% -$550K 0.01% 388
2025
Q2
$1.38M Sell
3,539
-91
-3% -$36.6K 0.02% 365
2025
Q1
$1.58M Sell
3,630
-83
-2% -$33.3K 0.03% 340
2024
Q4
$1.37M Sell
3,713
-858
-19% -$359K 0.02% 366
2024
Q3
$2.38M Buy
+4,571
New +$2.44M 0.04% 281
2023
Q3
$246K Buy
566
+6
+1% +$2.72K 0.01% 319
2023
Q2
$249K Buy
+560
New +$258K 0.01% 335

Other funds holding ELV

Wilmington Savings Fund Society's ELV Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its Elevance Health (ELV) stake by 6.3% in Q2 2026, buying an estimated $43.4K and bringing the position to 1,963 shares worth $759K. The position accounts for 0.02% of the portfolio, ranked #352.

Wilmington Savings Fund Society first reported a position in ELV in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.38M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wilmington Savings Fund Society held 1,963 shares of Elevance Health worth $759K as of Q2 2026.
  • Wilmington Savings Fund Society bought 117 Elevance Health shares in Q2 2026, an estimated $43.4K.
  • Elevance Health made up 0.02% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #352 holding.
  • Wilmington Savings Fund Society first reported a position in Elevance Health in Q2 2023 and has held it in 10 quarters since.
  • Wilmington Savings Fund Society's Elevance Health position peaked at $2.38M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.